Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2017

Open Access 01-12-2017 | Research article

Hepatitis C hospitalizations in Spain, 2004-2013: a retrospective epidemiological study

Authors: R. Boix, R. Cano, P. Gallego, F. Vallejo, R. Fernández-Cuenca, I. Noguer, A. Larrauri

Published in: BMC Health Services Research | Issue 1/2017

Login to get access

Abstract

Background

Hepatitis C is an important public health problem about which there is currently scarce epidemiological information. The objective of this study is to describe and analyse the demographic and epidemiological characteristics of hospitalized cases of hepatitis C in the Spanish population between 2004 and 2013.

Methods

The study uses the Hospital Discharge Records Database of the Spanish National Health System. It is a retrospective descriptive epidemiological study. The variables analysed were year of infection, age, sex, diagnostic category, days admitted and co-morbidity.

Results

There have been a total of 351,996 hospitalizations; 225,138 men (64%) and 126,858 women (36%). They are divided between acute hepatitis 8161 (2.3%); chronic hepatitis 325,185 (92.4%) and unspecified hepatitis 18,650 (5.3%). The mean age for men is 53.7 (+/−15.2) and for women 62.3 (+/−17.3). 22.8% also present with an Human immunodeficiency virus (HIV) disease coinfection, and 14.7% with opioid dependencies. The trend is for a gradual increase in cases without statistical significance.

Conclusions

The Hepatitis C cases hospitalized had high levels of chronicity, which entails two distinct patterns of illness in men and women – who are affected in different age ranges.
Literature
1.
World Health Organization. Guidelines for the screening, care and treatment of persons with hepatitis C infection. Geneva: World Health Organization; 2014.
2.
European Centre for Disease Prevention and Control. Hepatitis C surveillance in Europe – 2013. Stockholm: ECDC; 2015.
3.
Bruguera M, Forns X. Hepatitis C in Spain. Med Clin (Barc). 2006;127:113–7.CrossRef
4.
Riestra S, Fernández E, Leiva P, Garcia S, Ocio G, Rodrigo L. Prevalence of hepatitis C virus infection in the general population of northern Spain. Eur J Gastroenterol Hepatol. 2001;13:477–81.CrossRefPubMed
5.
Domínguez A, Bruguera M, Vidal J, Plans P, Salleras L. Community-based seroepidemiological survey of HCV infection in Catalonia. Spain J Med Virol. 2001;65:688–93.CrossRefPubMed
6.
Sola R, Cruz de Castro E, Hombrados M, Planas R, Coll S, Jardi R, et al. Prevalence of hepatitis B and hepatitis C viruses in different counties of Catalonia, Spain: cross-sectional study. Med Clin (Barc). 2002;119:90–5.CrossRef
7.
Chimeno MM, Chocarro A, Brezmes P, Ochoa C, Perez J. Seroprevalence of hepatitis C virus in the general population. Enferm Infecc Microbiol Clin. 2002;20:64–7.CrossRefPubMed
8.
López-Izquierdo R, Udaondo MA, Zarzosa P, García-Ramón E, Garcinuño S, Bratos MA, et al. Seroprevalence of viral hepatitis in a representative general population of an urban public health area in Castilla y Leon (Spain). Enferm Infecc Microbiol Clin. 2007;25:317–23.CrossRefPubMed
9.
Gil Miguel A, Ruedas A, Santos Santos M, Rey Calero YJ. Prevalence of hepatitis C virus infection in school children in an urban and suburban area of Madrid. Aten Primaria. 1996;17:521–2.PubMed
10.
Suárez González A, Solís Sánchez G, Otero Guerra L, de la Guerra G V, Navascués C Á, López R G. The prevalence of markers for the hepatitis a and B viruses in the population of Gijón between 6 and 25 years old. Gastroenterol Hepatol. 2004;27:347–52.CrossRefPubMed
11.
Gutiérrez-Zufiaurre N, Sánchez-Hernandez J, Muñoz S, Marín R, Delgado N, Sáenz MC, et al. Seroprevalence of antibodies against Treponema pallidum, Toxoplasma gondii, rubella virus, hepatitis B and C virus, and HIV in pregnant women. Enferm Infecc Microbiol Clin. 2004;22:512–6.CrossRefPubMed
12.
Ruiz-Extremera A, López-Garrido MA, Barranco E, Quintero MD, Ocete-Hita E, de Rueda P M, et al. Activity of hepatic enzymes from week sixteen of pregnancy. Am J Obstet Gynecol. 2005;193:2010–6.CrossRefPubMed
13.
Calleja Panero JL, Llop Herrera E, Ruiz Moraga M, de la Revilla NJ, Calvo Bonacho E, Pons Renedo F, et al. Prevalence of viral hepatitis (band C) serological markers in healthy working population. Rev Esp Enferm Dig. 2013;105:249–54.CrossRefPubMed
14.
15.
Gower E, et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(Suppl 1):45–57.CrossRef
16.
Bruggmann P, et al. Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat. 2014;21(Suppl. 1):5–33.CrossRefPubMed
17.
García-Fulgueiras A, García-Pina R, Morant C, García-Ortuzar V, Génova R, Álvarez E. Hepatitis C and hepatitis B related mortality in Spain. Eur J Gastroenterol Hepatol. 2009;21:895–901.CrossRefPubMed
18.
García-Fulgueiras A, García-Pina C, Morant N, de Larrea-Baz F, Álvarez E. Burden of disease related to hepatitis C and hepatitis B in Spain: a methodological challenge of an unfolding health problem. J Viral Hepat. 2011;18:453–60.CrossRef
19.
20.
21.
Esteban-Vasallo MD, Domínguez-Berjón MF, Gil de Miguel Á, Astray-Mochales J, Blanco-Ancos LM, Gil-Prieto R. Characteristics of herpes zoster-associated hospitalizations in Madrid (SPAIN) before vaccine availability. J Inf Secur. 2016;72:70–9.
22.
Gil-Prieto R, Gonzalez-Escalada A, Alvaro-Meca A, Garcia-Garcia L, San-Martin M, González-López A, Gil-de-Miguel A. Impact of non-routine rotavirus vaccination on hospitalizations for diarrhoea and rotavirus infections in Spain. Vaccine. 2013;31:5000–4.CrossRefPubMed
23.
López-de-Andrés A, Jiménez-García R, Hernández-Barrera V, Isabel Jiménez-Trujillo M, Gil-de-Miguel A, Carrasco-Garrido P. Trends in hospitalizations among children with type 1 diabetes in Spain, 2001-2009. J Pediatr Endocrinol Metab. 2013;26:85–9.CrossRefPubMed
24.
25.
Waterhouse J, Muir CS, Correa P, Powell J, editors. Cancer incidence in five continents. Lyon: IARC Scientific Publications; 1976.
26.
Diez M, Garriga C, Pons M, Ten A, Marcos H, Gutiérrez G, et al. A low-cost, sustainable, second generation system for surveillance of people living with HIV in Spain: 10-year trends in behavioural and clinical indicators, 2002 to 2011. Euro Surveill. 2014; 19 (20): pii=20805.
27.
Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011;378:571–83.CrossRefPubMedPubMedCentral
28.
Rondy M, Wiessing I, Hutchinson SJ, Mathei C, Mathis F, Mravcik V, et al. Hepatitis C prevalence in injecting drug users in Europe, 1990–2007: impact of study recruitment setting. Epidemiol Infect. 2013;141:563–72.CrossRefPubMed
29.
Martínez-Rebollar M, Mallolas J, Pérez I, González-Cordón A, Loncà M, Torres B, et al. Acute outbreak of hepatitis C in human immunodeficiency virus-infected patients. Enferm Infecc Microbiol Clin. 2015;33:3–8.CrossRefPubMed
30.
Martínez-Bauer E, Forns X, Armelles M, Planas R, Solà R, Vergara M, et al. Hospital admission is a relevant source of hepatitis C virus acquisition in Spain. J Hepatol. 2008;48:20–7.CrossRefPubMed
31.
Echevarría JM, León P, Pozo F, Avellón A. Follow-up of the prevalence of hepatitis C virus genotypes in Spain during a nine-year period (1996-2004). Enferm Infecc Microbiol Clin. 2006;24(1):20–5.CrossRefPubMed
32.
Razavi H, Waked I, Sarrazin C, Myers RP, Idilman R, Calinas F, et al. The present and future disease burden of hepatitis C virus (HCV) infection with today’s treatment paradigm. J Viral Hepat. 2014;21(Suppl. 1):34–59.CrossRefPubMed
33.
Dore GJ, Ward J, Thursz M. Hepatitis C disease burden and strategies to manage the burden. J Viral Hepat. 2014;21:1–4.CrossRefPubMed
Metadata
Title
Hepatitis C hospitalizations in Spain, 2004-2013: a retrospective epidemiological study
Authors
R. Boix
R. Cano
P. Gallego
F. Vallejo
R. Fernández-Cuenca
I. Noguer
A. Larrauri
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2017
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-017-2410-1

Other articles of this Issue 1/2017

BMC Health Services Research 1/2017 Go to the issue

Research article

Doctors’ opinion on the contribution of coordination mechanisms to improving clinical coordination between primary and outpatient secondary care in the Catalan national health system

Research article

Implementation of a guideline for local health policy making by regional health services: exploring determinants of use by a web survey

Research article

Living with dementia in a nursing home, as described by persons with dementia: a phenomenological hermeneutic study

Research article

Development and validation of a structured observation scale to measure responsiveness of physicians in rural Bangladesh

Study protocol

Three approaches to glucose monitoring in non-insulin treated diabetes: a pragmatic randomized clinical trial protocol

Research article

Relationships between structure, process and outcome to assess quality of integrated chronic disease management in a rural South African setting: applying a structural equation model